Cargando…
An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
Recent advances in cellular therapies for patients with cancer, including checkpoint blockade and ex vivo-expanded, tumor-specific T cells, have demonstrated that targeting the immune system is a powerful approach to the elimination of tumor cells. Clinical efforts have also demonstrated limitations...
Autores principales: | Lieberman, Nicole A. P., DeGolier, Kole, Haberthur, Kristen, Chinn, Harrison, Moyes, Kara W., Bouchlaka, Myriam N., Walker, Kirsti L., Capitini, Christian M., Crane, Courtney A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801405/ https://www.ncbi.nlm.nih.gov/pubmed/29456538 http://dx.doi.org/10.3389/fimmu.2018.00150 |
Ejemplares similares
-
Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma
por: Gardell, Jennifer L, et al.
Publicado: (2020) -
Small molecule Photoregulin3 prevents retinal degeneration in the Rho(P23H) mouse model of retinitis pigmentosa
por: Nakamura, Paul A, et al.
Publicado: (2017) -
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses
por: Brempelis, Katherine J, et al.
Publicado: (2020) -
Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2(+) Murine Neuroblastoma
por: Bates, Paul D., et al.
Publicado: (2021) -
Uncoupled evolution of the Polycomb system and deep origin of non-canonical PRC1
por: de Potter, Bastiaan, et al.
Publicado: (2023)